info@cytospector.com
Cytospector
  • Home
  • Expertise
  • High-content assays
    • Standardized phenotypic assay
    • Alzheimer´s disease assay
    • Schizophrenia assay
  • Assay development
  • About us
  • Contact
  • Home
  • Expertise
  • High-content assays
    • Standardized phenotypic assay
    • Alzheimer´s disease assay
    • Schizophrenia assay
  • Assay development
  • About us
  • Contact
slider-kleur-1

Cytospector’s advanced high-content screening technology
allows high-throughput analysis of
neuronal and synaptic phenotypes

slider-kleur-3

Our rodent primary neurons and human iPS cell-derived neurons
ideally represent neural processes and disease mechanisms

slider-kleur-2

Cytospector specializes in monitoring disease-relevant changes in
synapse formation, morphology, and synaptic transmission

slider-kleur-4

Patch clamp analysis of single neurons
characterizes synaptic transmission in detail

STANDARDIZED PHENOTYPIC ASSAY

based on a variety of cellular and synaptic parameters

Read More

ALZHEIMER'S DISEASE ASSAY

For compound or genetics screens

Read More

SCHIZOPHRENIA ASSAY

For compound or genetic screens

Read More

ASSAY DEVELOPMENT

For compound or genetics screens

Read More

Cytospector: what we do best!

Cytospector offers standardized and customized neuron-based high-content assays for compound screening and target identification (e.g. genetic screens) in the field of neurological and psychiatric disease. We use rodent primary neurons and human induced pluripotent stem (iPS) cell-derived neurons, which ideally represent neural processes and disease mechanisms, and have a unique expertise in monitoring disease-relevant changes in synapse formation, morphology, and synaptic transmission.

About Cytospector

Afbeelding-1

Cytospector expertise

Cytospector’s experimental set-up allows for large scale, highly sensitive and reproducible enhancer suppressor or compound screens for a range of CNS relevant phenotypes. Our fully automated cell culture integrated with automated imaging analysis has been validated in a number of screens for neurodegenerative diseases as well as neurotoxicity.

  • Rodent primary neurons and human iPS cell-derived neurons
  • Detailed analysis of synaptic phenotypes
  • High-content microscopy
  • High-content analysis of synaptic transmission
Read more

High-content assays

Neuron-based high-content assays for compound and genetic screens Using primary rodent neurons and human iPS cell-derived neurons, Cytospector provides high-content, high-throughput cellular screens for a variety of cellular and synaptic phenotypes that are relevant for neurological and psychiatric diseases. Cytospector offers the following assays:

  • Standardized phenotypic assay for neuronal and synaptic morphology and function
  • Alzheimer’s disease assay
  • Schizophrenia assay
  Read more

afbeelding2

video-cyto

Assay development

On demand, Cytospector develops neuron-based high-content assays for compound screens and screens for therapeutic targets in the field of neurological and psychiatric disease.

Combination of advanced neuronal cell models, standardized analysis of a large number of relevant neuronal and synaptic phenotypes, and our long-standing expertise with high-content screening ensures optimal assay development.

Contact us with any questions or requests for assay development.

Contact

CYTOSPECTOR

  • Home
  • Expertise
  • High-content assays
  • Standardized phenotypic assay
  • Alzheimer´s disease assay
  • Assay development
  • About us
  • Contact

CONTACT

Cytospector
PO Box 71033
1008 BA Amsterdam
The Netherlands

info@cytospector.com

© Copyright 2015 •Cytospector •